MONOCLONAL ANTIBODIES HAVING HOMOSUBTYPE CROSS -NEUTRALIZATION PROPERTIES AGAINST INFLUENZA A VIRUSES SUBTYPE H1
- 专利权人:
- POMONA RICERCA S.R.L
- 发明人:
- BURIONI, ROBERTO,CLEMENTI, MASSIMO
- 申请号：
- NZ59011509
- 公开号：
- NZ590115A
- 申请日:
- 2009.05.27
- 申请国别(地区):
- NZ
- 年份:
- 2012
- 代理人:
- 摘要：
- A human monoclonal antibody directed against the haemagglutinin of the influenza A virus. The antibody has neutralising activity against a plurality of H1-subtype influenza A viruses comprising at least one human-derived isolate and one animal-derived isolate. The antibody can recognise A/Puerto Rico/8/34, A/Wilson-Smith/33 and A/Malaya/302/54 and A/California/04/2009.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Influenza virus vaccines and uses thereof
- РЕКОМБИНАНТНАЯ ПСЕВДОАДЕНОВИРУСНАЯ ЧАСТИЦА НА ОСНОВЕ ГЕНОМА АДЕНОВИРУСА ЧЕЛОВЕКА 5 СЕРОТИПА ДЛЯ ИНДУКЦИИ СПЕЦИФИЧЕСКОГО ИММУНИТЕТА К ВИРУСУ ГРИППА А СУБТИПА Н1N1 И СПОСОБ ЕЕ ИСПОЛЬЗОВАНИЯ В КАЧЕСТВЕ КОМПОНЕНТА ДЛЯ СОЗДАНИЯ ВАКЦИНЫ
- 재조합 베큘로바이러스, 재조합 베큘로바이러스를 포함하는 바이러스 유사입자 및 돼지 신종인플루엔자 바이러스 감염 억제용 백신
- Inactivated split influenza virus from influenza strain A / California / 7/2009 (H1N1) (X-179A), if desired from a pandemic influenza strain in an officially declared pandemic situation
- ATTENUATED COLD-ADAPTED INFLUENZA VIRUS STRAIN A/PR/8/59/M2 (H1N1) APPLICABLE FOR VACCINAL INFLUENZA VIRUS STRAINS AS ATTENUATION DONOR, VACCINAL INFLUENZA VIRUS STRAINS A/59/M2/CALIFORNIA/66/2211 (H2N2) AND A/59/M2/TOKYO/67/22111 (H2N2)
